Brugada Ablation of VF Substrate Ongoing MultiCenter Registry
- Conditions
- Brugada Syndrome
- Interventions
- Procedure: Catheter Ablation
- Registration Number
- NCT04420078
- Lead Sponsor
- Pacific Rim Electrophysiology Research Institute
- Brief Summary
Current treatment of high-risk Brugada Syndrome (BrS) patients (pts) with recurrent VF is limited. Catheter ablation (CA) has been performed for BrS but a large study with long-term outcomes of CA in BrS ablation are lacking.
- Detailed Description
Brugada syndrome (BrS) patients who undergo BRS substrate ablations from tertiary centers for catheter ablations of complex arrhythmias from three continents - Asia, Europe and North America - are registered in a common database. The investigators exclude patients who were lost to follow up in the outpatient clinic.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 159
- Symptomatic Brugada Syndrome patients who had undergone catheter ablation of the arrhythmogenic substrates.
- Patients who will not commit to regular follow up.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CA BrS Catheter Ablation Symptomatic BrS patients who underwent catheter ablation of the BrS/VF substrate
- Primary Outcome Measures
Name Time Method Death 3 years Expiration, unrelated to procedure
ICD Therapy for VT/VF 3 years Electrical therapy delivered through device for termination of VF episodes
- Secondary Outcome Measures
Name Time Method Inappropriate ICD Therapy 3 years Caused by lead sensing or programming errors
Normalization of Brugada ECG pattern 3 years ECG pattern is normal sinus rhythm after catheter ablation
Trial Locations
- Locations (1)
Pacific Rim Electrophysiology Research Institute, Chulalongkorn University
🇹ðŸ‡Bangkok, Thailand